KCNK1 | Potassium channel, subfamily K, member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Mixed |
KCNK13 | Potassium channel, subfamily K, member 13 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNK15 | Potassium channel, subfamily K, member 15 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNK16 | Potassium channel, subfamily K, member 16 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNK17 | Potassium channel, subfamily K, member 17 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNK18 | Potassium channel, subfamily K, member 18 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Not detected |
KCNK2 | Potassium channel, subfamily K, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNK3 | Potassium channel, subfamily K, member 3 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNK5 | Potassium channel, subfamily K, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNK6 | Potassium channel, subfamily K, member 6 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNK9 | Potassium channel, subfamily K, member 9 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
KCNMA1 | Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNN2 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNN3 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNN4 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNQ4 | Potassium voltage-gated channel, KQT-like subfamily, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNQ5 | Potassium voltage-gated channel, KQT-like subfamily, member 5 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNS2 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNS3 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNT1 | Potassium channel, subfamily T, member 1 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
KCNT2 | Potassium channel, subfamily T, member 2 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNV2 | Potassium channel, subfamily V, member 2 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
MCOLN1 | Mucolipin 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Expressed in all |
MCOLN2 | Mucolipin 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
MCOLN3 | Mucolipin 3 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
PKD2 | Polycystic kidney disease 2 (autosomal dominant) | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Expressed in all |
PKD2L1 | Polycystic kidney disease 2-like 1 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
PKD2L2 | Polycystic kidney disease 2-like 2 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
SCN11A | Sodium channel, voltage-gated, type XI, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
SCN2A | Sodium channel, voltage-gated, type II, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
SCN3A | Sodium channel, voltage-gated, type III, alpha subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
SCN4A | Sodium channel, voltage-gated, type IV, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
SCN9A | Sodium channel, voltage-gated, type IX, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
TPCN1 | Two pore segment channel 1 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Expressed in all |
TPCN2 | Two pore segment channel 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Expressed in all |
TRPA1 | Transient receptor potential cation channel, subfamily A, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
TRPC1 | Transient receptor potential cation channel, subfamily C, member 1 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
TRPC3 | Transient receptor potential cation channel, subfamily C, member 3 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
TRPC6 | Transient receptor potential cation channel, subfamily C, member 6 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
TRPC7 | Transient receptor potential cation channel, subfamily C, member 7 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Not detected |
TRPM1 | Transient receptor potential cation channel, subfamily M, member 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
TRPM4 | Transient receptor potential cation channel, subfamily M, member 4 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
TRPM5 | Transient receptor potential cation channel, subfamily M, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
TRPM6 | Transient receptor potential cation channel, subfamily M, member 6 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
TRPM7 | Transient receptor potential cation channel, subfamily M, member 7 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Expressed in all |
TRPV4 | Transient receptor potential cation channel, subfamily V, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
TRPV5 | Transient receptor potential cation channel, subfamily V, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
TRPV6 | Transient receptor potential cation channel, subfamily V, member 6 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |